◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › EUDA

EUDA Health Holdings Limited (EUDA) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Real Estate · Real Estate Services · DATA UPDATED 2026-07-09

EUDA Health Holdings Limited (EUDA) operates in the Real Estate Services industry and is headquartered in Singapore, Singapore with about 123 employees. Its market capitalization is roughly $37 million. In the fiscal year ended 2025-12-31, EUDA reported $7M in revenue and ($3M) in net income.

EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services.

Interactive charts & full statements → Open the EUDA valuation workbench →

EUDA Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$7M$4M$4M$4M
Gross Profit$3M$1M$1M$1M
Operating Income (EBIT)($2M)($3M)($4M)($6M)
Net Income($3M)($15M)($10M)($25M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EUDA Free Cash Flow History

EUDA Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$2M$2M$1M$26M
Total Liabilities$6M$4M$9M$29M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EUDA viewer.

Other Companies in Real Estate Services

← EUAll stocksEURK →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.